JPWO2021224901A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021224901A5 JPWO2021224901A5 JP2024509421A JP2024509421A JPWO2021224901A5 JP WO2021224901 A5 JPWO2021224901 A5 JP WO2021224901A5 JP 2024509421 A JP2024509421 A JP 2024509421A JP 2024509421 A JP2024509421 A JP 2024509421A JP WO2021224901 A5 JPWO2021224901 A5 JP WO2021224901A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- cyclosporine
- weight
- stable
- nanomicelle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 47
- 238000009472 formulation Methods 0.000 claims 33
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 18
- 108010036949 Cyclosporine Proteins 0.000 claims 15
- 229960001265 ciclosporin Drugs 0.000 claims 15
- 229930182912 cyclosporin Natural products 0.000 claims 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 12
- 239000008215 water for injection Substances 0.000 claims 12
- 238000000034 method Methods 0.000 claims 10
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 6
- 229920002675 Polyoxyl Polymers 0.000 claims 6
- 239000008186 active pharmaceutical agent Substances 0.000 claims 6
- 239000004359 castor oil Substances 0.000 claims 6
- 235000019438 castor oil Nutrition 0.000 claims 6
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 6
- 229920004914 octoxynol-40 Polymers 0.000 claims 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 6
- 229940069328 povidone Drugs 0.000 claims 6
- 239000011780 sodium chloride Substances 0.000 claims 6
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims 6
- 229940061607 dibasic sodium phosphate Drugs 0.000 claims 4
- 238000004090 dissolution Methods 0.000 claims 3
- 229910000397 disodium phosphate Inorganic materials 0.000 claims 2
- 235000019800 disodium phosphate Nutrition 0.000 claims 2
- -1 The formulation Chemical compound 0.000 claims 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 claims 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims 1
- 235000019799 monosodium phosphate Nutrition 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202121037917 | 2021-08-20 | ||
| IN202121037917 | 2021-08-20 | ||
| PCT/IB2021/059176 WO2021224901A2 (en) | 2021-08-20 | 2021-10-06 | Stable cyclosporine ophthalmic formulation and manufacturing process thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024530244A JP2024530244A (ja) | 2024-08-16 |
| JPWO2021224901A5 true JPWO2021224901A5 (https=) | 2024-10-16 |
| JP2024530244A5 JP2024530244A5 (https=) | 2024-10-16 |
Family
ID=78468801
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509421A Pending JP2024530244A (ja) | 2021-08-20 | 2021-10-06 | 安定なシクロスポリン眼科用製剤及びその製造プロセス |
| JP2024509422A Pending JP2024530245A (ja) | 2021-08-20 | 2022-08-22 | 安定なシクロスポリン眼科用製剤及びその製造プロセス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509422A Pending JP2024530245A (ja) | 2021-08-20 | 2022-08-22 | 安定なシクロスポリン眼科用製剤及びその製造プロセス |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20240342086A1 (https=) |
| EP (2) | EP4387589A4 (https=) |
| JP (2) | JP2024530244A (https=) |
| CN (2) | CN117957011A (https=) |
| AU (2) | AU2021267217A1 (https=) |
| IL (2) | IL310823A (https=) |
| MX (2) | MX2024002234A (https=) |
| WO (2) | WO2021224901A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4719350A1 (en) * | 2023-05-29 | 2026-04-08 | Sun Pharmaceutical Industries Limited | Stable cyclosporine ophthalmic formulation and manufacturing process thereof |
| WO2025163677A1 (en) * | 2024-01-31 | 2025-08-07 | Registrar, Panjab University, Chandigarh | Nanomicellar composition for high permeation and extended-release drug delivery system |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2836946C (en) * | 2011-05-27 | 2017-08-01 | Allergan, Inc. | A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof |
| PL2887923T3 (pl) * | 2012-08-24 | 2023-08-14 | Sun Pharmaceutical Industries Limited | Preparat okulistyczny polioksylipidu lub polioksylowego kwasu tłuszczowego i leczenie chorób oczu |
| US20200237859A1 (en) * | 2019-01-25 | 2020-07-30 | Newport Research, Inc. | Aqueous suspensions of cyclosporin |
| EP3373976B1 (en) * | 2015-11-10 | 2024-01-03 | Sun Pharmaceutical Industries Limited | Topical formulations and uses thereof |
| US10918694B2 (en) * | 2016-02-29 | 2021-02-16 | Sun Pharma Global Fze | Topical cyclosporine-containing formulations and uses thereof |
-
2021
- 2021-10-06 WO PCT/IB2021/059176 patent/WO2021224901A2/en not_active Ceased
- 2021-10-06 JP JP2024509421A patent/JP2024530244A/ja active Pending
- 2021-10-06 US US18/683,943 patent/US20240342086A1/en active Pending
- 2021-10-06 CN CN202180102266.5A patent/CN117957011A/zh active Pending
- 2021-10-06 AU AU2021267217A patent/AU2021267217A1/en active Pending
- 2021-10-06 EP EP21800075.0A patent/EP4387589A4/en active Pending
- 2021-10-06 IL IL310823A patent/IL310823A/en unknown
- 2021-10-06 MX MX2024002234A patent/MX2024002234A/es unknown
-
2022
- 2022-08-22 US US18/683,932 patent/US20240423912A1/en active Pending
- 2022-08-22 CN CN202280007116.0A patent/CN116528838A/zh active Pending
- 2022-08-22 IL IL310887A patent/IL310887A/en unknown
- 2022-08-22 JP JP2024509422A patent/JP2024530245A/ja active Pending
- 2022-08-22 AU AU2022330409A patent/AU2022330409A1/en active Pending
- 2022-08-22 EP EP22768958.5A patent/EP4387591A1/en active Pending
- 2022-08-22 WO PCT/IB2022/057851 patent/WO2023021492A1/en not_active Ceased
- 2022-08-22 MX MX2024002235A patent/MX2024002235A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910007511A (ko) | 콜라겐 함유 안약 제형 | |
| JPWO2021224901A5 (https=) | ||
| CN1322131A (zh) | 含尼美舒利的局部药用组合物 | |
| IL310887A (en) | Stable cyclosporine ophthalmic formulation and its manufacturing process | |
| CN110665430A (zh) | 一种耐酸型绿色皮克林乳化剂的制备方法及其皮克林乳化剂 | |
| JPH0390024A (ja) | 眼疾患を処置するための5―メチル―イソオキサゾール―4―カルボン酸アニリド類または2―ヒドロキシエチリデン―シアノ酢酸アニリド類含有医薬組成物 | |
| JP2002524410A (ja) | リプスタチン誘導体−可溶性繊維錠剤 | |
| JPWO2023021492A5 (https=) | ||
| US4602040A (en) | Meclofenamic acid topical pharmaceutical composition | |
| JP2002284673A (ja) | 生理学的に許容可能な水溶液の調製法およびこの方法により得られた溶液 | |
| JP5500162B2 (ja) | 点眼剤 | |
| JP4294276B2 (ja) | 点眼剤組成物 | |
| CN111358758A (zh) | 一种盐酸溴己新分散片及其制备方法 | |
| CN116850140A (zh) | 一种注射用氨苄西林钠舒巴坦钠药物组合物及其制备方法 | |
| CN1218689C (zh) | 包含妥布霉素和黄原胶的药物组合物 | |
| US20110053877A1 (en) | Nimesulide and muscle relaxant combinations thereof | |
| RU2409346C2 (ru) | Водный гель для местного применения высокой стабильности на основе метронидазола и способ его получения | |
| CN117089084A (zh) | 一种新型水凝胶的制备方法 | |
| CN111803464A (zh) | 一种塞来昔布胶囊制剂 | |
| US20060270708A1 (en) | Novel process for preparation of isotonic aqueous injection of ropivacaine | |
| JP4961671B2 (ja) | 点眼剤 | |
| JPH02164829A (ja) | ヒアルロン酸点眼液 | |
| JP4779382B2 (ja) | 点眼剤用組成物 | |
| JP2002518348A5 (https=) | ||
| JP2005239658A (ja) | 点眼剤 |